Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fellowships and Scholarships | 1 | 2020 | 323 | 0.510 |
Why?
|
| Thyroid Neoplasms | 4 | 2021 | 249 | 0.480 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1427 | 0.310 |
Why?
|
| Hypothyroidism | 2 | 2020 | 77 | 0.210 |
Why?
|
| Thyroidectomy | 3 | 2021 | 101 | 0.200 |
Why?
|
| Thyroid Gland | 1 | 2021 | 98 | 0.170 |
Why?
|
| Puberty, Precocious | 1 | 2020 | 27 | 0.160 |
Why?
|
| Carcinoma, Papillary | 1 | 2020 | 92 | 0.160 |
Why?
|
| Biomarkers, Tumor | 2 | 2020 | 1608 | 0.160 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 284 | 0.150 |
Why?
|
| Phenylurea Compounds | 1 | 2018 | 56 | 0.140 |
Why?
|
| Educational Measurement | 1 | 2020 | 316 | 0.130 |
Why?
|
| Quinolines | 1 | 2018 | 117 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 417 | 0.130 |
Why?
|
| Learning | 1 | 2020 | 371 | 0.130 |
Why?
|
| Hypocalcemia | 1 | 2017 | 36 | 0.130 |
Why?
|
| Pyriform Sinus | 1 | 2016 | 8 | 0.120 |
Why?
|
| Thyroid Diseases | 1 | 2016 | 28 | 0.120 |
Why?
|
| Fistula | 1 | 2016 | 49 | 0.120 |
Why?
|
| Thyroid Nodule | 1 | 2015 | 22 | 0.110 |
Why?
|
| Gene Fusion | 1 | 2015 | 58 | 0.110 |
Why?
|
| Curriculum | 1 | 2020 | 784 | 0.110 |
Why?
|
| Mutation | 2 | 2020 | 6129 | 0.110 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2015 | 170 | 0.110 |
Why?
|
| Endoscopy | 1 | 2016 | 270 | 0.100 |
Why?
|
| Carcinoma | 1 | 2015 | 284 | 0.100 |
Why?
|
| Catheter Ablation | 1 | 2016 | 320 | 0.090 |
Why?
|
| Child | 7 | 2021 | 26159 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1541 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2021 | 3105 | 0.070 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2009 | 114 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 1788 | 0.070 |
Why?
|
| Adolescent | 7 | 2021 | 20731 | 0.070 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2009 | 157 | 0.060 |
Why?
|
| Lymphatic Metastasis | 2 | 2020 | 424 | 0.060 |
Why?
|
| Hemangioendothelioma | 1 | 2007 | 25 | 0.060 |
Why?
|
| Adult | 4 | 2021 | 31125 | 0.060 |
Why?
|
| AIDS Serodiagnosis | 1 | 2004 | 52 | 0.050 |
Why?
|
| Insulin | 1 | 2009 | 1146 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2009 | 683 | 0.050 |
Why?
|
| Humans | 11 | 2021 | 130403 | 0.050 |
Why?
|
| Female | 10 | 2021 | 70343 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2009 | 1262 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2004 | 489 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5204 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2021 | 17633 | 0.040 |
Why?
|
| Prognosis | 2 | 2020 | 4901 | 0.040 |
Why?
|
| Syndrome | 1 | 2020 | 1160 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2007 | 1132 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2021 | 553 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2021 | 800 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 1395 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2015 | 39 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 2298 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1233 | 0.030 |
Why?
|
| Telomerase | 1 | 2015 | 152 | 0.030 |
Why?
|
| beta Catenin | 1 | 2015 | 199 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 9974 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 219 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 629 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 788 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2020 | 14982 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 528 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1211 | 0.020 |
Why?
|
| HIV Infections | 1 | 2004 | 2011 | 0.020 |
Why?
|
| Logistic Models | 1 | 2017 | 1807 | 0.020 |
Why?
|
| Male | 4 | 2020 | 64486 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 1221 | 0.020 |
Why?
|
| Biopsy | 1 | 2015 | 1239 | 0.020 |
Why?
|
| Risk Factors | 2 | 2017 | 10981 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 913 | 0.020 |
Why?
|
| Infant | 2 | 2020 | 13276 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2835 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2018 | 12852 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8525 | 0.020 |
Why?
|
| Transplantation Conditioning | 1 | 2009 | 325 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2007 | 50 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2009 | 233 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2007 | 53 | 0.020 |
Why?
|
| Thyroxine | 1 | 2007 | 59 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 4475 | 0.010 |
Why?
|
| Gravidity | 1 | 2004 | 12 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2009 | 1103 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2004 | 143 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 3410 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 3692 | 0.010 |
Why?
|
| Pregnancy | 1 | 2004 | 7423 | 0.010 |
Why?
|